Pfizer Bicillin L-A Injectable Suspension Recalled for Manufacturing Defects
Pfizer is recalling approximately 19,279 vials of Bicillin L-A (penicillin G benzathine) injectable suspension due to manufacturing deviations and particulates identified during visual inspection. The affected vials were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving a manufacturing defect (particulates) in an injectable drug. No illnesses or injuries have been reported, but particulates in an injectable product pose a significant risk of harm. The score reflects the serious nature of the manufacturing defect without reported actual patient harm.
Plain-English summary
Pfizer Inc. is recalling Bicillin L-A (penicillin G benzathine) injectable suspension, 2,400,000 units per 4 mL, due to Current Good Manufacturing Practice (CGMP) deviations and particulates identified during visual inspection. Approximately 19,279 vials are affected in this recall.
The recalled product includes lots GT2598 and GT2599 (exp. 09/30/26), HK2909 (exp. 02/28/27), HR9969 (exp. 04/30/27), and HR9984 (exp. 08/31/27). The vials were manufactured in Austria and distributed nationwide in the United States.
Healthcare providers and patients should not use the recalled vials. Consult your healthcare provider if you have received an injection from one of the affected lots.
The recalled product
- Product
- BICILLIN L-A (PENICILLIN G BENZATHINE)
- Brand
- BICILLIN L-A
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable Antibiotic
- Hazard
- particulates
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots GT2598
- GT2599
- Exp 09/30/26
- HK2909
- Exp 02/28/27
- HR9969
- Exp 04/30/27
- HR9984
- Exp 08/31/27.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BICILLIN L-A
- HighPfizer Recalls Bicillin L-A Injectable Antibiotic Due to Manufacturing Particulates
FDA (Drugs) · 2025-08-06
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27